<DOC>
	<DOCNO>NCT03012815</DOCNO>
	<brief_summary>The current `` gold-standard '' management alcohol withdrawal syndrome ( AWS ) symptom-triggered administration benzodiazepine . This method treatment several drawback describe literature . Thus benzodiazepine spar agent evaluate use AWS . One agent show benefit AWS also benefit complete abstinence , reduce return heavy drinking , craving gabapentin . In clinical practice Mayo Clinic gabapentin use purpose . Due limit report safety efficacy protocol involve gabapentin AWS , study compare gabapentin symptom-triggered lorazepam complete .</brief_summary>
	<brief_title>Gabapentin Alcohol Withdrawal Syndrome</brief_title>
	<detailed_description>The current `` gold-standard '' management alcohol withdrawal syndrome symptom-triggered administration benzodiazepine . Benzodiazepines use symptom-triggered approach several drawback administration medication due many subjective patient report symptom . Benzodiazepines may contribute drug-induced delirium high dosage may necessitate transfer ICU setting . Abrupt withdrawal benzodiazepine also contribute craving , rebound insomnia , anxiety show increase risk return drink . Clinical use gabapentin alcohol withdrawal present Maldonado Stanford University Hospitals . ( Academy Psychosomatic Medicine Annual Meeting , 2013-2015 ) At Mayo Clinic , Psychiatry Consultation-Liaison hospital service recommend use modify gabapentin protocol since January 2015 , clinically accept medical , surgical , psychiatric hospital service . The purpose research investigate reactive benzodiazepine versus proactive gabapentin approach AWS prospective , randomize , open-label study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Chlordiazepoxide</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Inclusion criterion 1 . Prediction Alcohol Withdrawal Severity Scale ( PAWSS ) score &gt; 4 . 2 . Adults age 18 old . 3 . Sufficient understanding English . 4 . Hospitalized Hospital Internal Medicine Generose . Exclusion criteria 1 . Severe renal impairment ( estimate CrCl &lt; 30 ) . 2 . Intensive Care Unit ( ICU ) level care . 3 . Not responsive due alcohol intoxication withdrawal . 4 . Already take gabapentin 300 mg three time day . 5 . Prescribed pregabalin . 6 . Primary seizure disorder . 7 . Acute benzodiazepine withdrawal . 8 . Concurrent substance use disorder ( opioid use disorder , stimulant use disorder ) disorder assess clinically significant . Cannabis use disorder allow . 9 . Concurrent anticonvulsant medication psychiatric indication ( e.g . bipolar disorder ) allow . 10 . Pregnancy . 11 . Involuntary legal status ( e.g. , court commitment ) . 12 . Patients admit great 12 hour prior potential enrollment . 13 . Patients receive therapeutic dose gabapentin ( rather continuation home dose ) prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>gabapentin</keyword>
	<keyword>Alcohol Withdrawal Syndrome</keyword>
	<keyword>benzodiazepine</keyword>
	<keyword>symptom-triggered</keyword>
</DOC>